June/July 2026, Vol 7, No 2

A look at how the synergy between artificial intelligence and clinical expertise is potentially shaping the outlook of cholangiocarcinoma care.

Uncover how clinical trials are transforming cholangiocarcinoma treatment, offering patients personalized therapies, expanded options, and new hope for the future.

Explore how cellular immunotherapy, from tumor-infiltrating lymphocytes to circulating tumor-reactive T cells, is expanding the treatment landscape for cholangiocarcinoma.

Antibody-drug conjugates show potential in cancer treatment and may signal new possibilities for biliary tract cancer patients in this significant exploration.

Hepatic arterial infusion pump chemotherapy is transforming treatment for intrahepatic cholangiocarcinoma by improving survival rates and enhancing quality of life.

Targeting protein arginine methyltransferases offers a promising new approach to combat cholangiocarcinoma by suppressing tumor growth and enhancing immune responses.

Discover how emergent research on CAR T-cell therapy is paving the way for new possibilities in cholangiocarcinoma treatment.

Cutting-edge research on therapeutic resistance and innovative combination strategies is adding new possibilities to the fight against cholangiocarcinoma.

The 13th Annual Cholangiocarcinoma Foundation Conference marked a milestone, with the largest in-person attendance ever. Researchers, clinicians, patients, caregivers, and advocates came together and presented the latest advancements in cholangiocarcinoma.